Abstract
Colorectal cancer is one of the most important causes of cancer morbidity and mortality in Western countries. While a myriad of healthful effects have been attributed to the probiotic lactic acid bacteria, perhaps the most controversial remains that of anticancer activity. It should be pointed out already at this point that there is no direct experimental evidence for cancer suppression in humans as a result of consumption of lactic cultures in fermented or unfermented dairy products. However, there is a wealth of indirect evidence, based largely on laboratory studies, in the literature. The precise mechanisms by which lactic acid bacteria may inhibit colon cancer are presently unknown. However, such mechanisms might include: enhancing the host’s immune response; binding and degrading potential carcinogens; quantitative and/or qualitative alterations in the intestinal microflora incriminated in producing putative carcinogen(s) and promoters (e.g. bile acid-degrading bacteria); producing antitumorigenic or antimutagenic compounds in the colon; alteration of the metabolic activities of intestinal microflora; alteration of physicochemical conditions in the colon; effects on physiology of the host. These potential mechanisms are discussed in the present paper.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abdelali H, Cassand P, Soussotte V, Daubeze M, Bouley C and Narbonne JF (1995) Effect of dairy products on initiation of precursor lesions of colon cancer in rats. Nutr. Cancer 24: 121–132
Arimochi H, Kinouchi T, Kataoka K, Kuwahara T and Ohnishi Y (1997) Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon. Biochem. Biophys. Res. Commun. 238: 753–757
Ayebo AD, Angelo IA and Shahani KM (1980) Effect of ingesting Lactobacillus acidophilus milk upon fecal flora and enzyme activity in humans. Milch Wissenschaft 35: 730–733
Bartram HP, Scheppach W, Gerlach S, Ruckdeschel G, Kelber E and Kasper H (1994) Does yogurt enriched with Bifidobacterium longum affect colonic microbiology and fecal metabolites in healthy subjects. Am. J. Clin. Nutr. 59: 428–432
Biffi A, Coradini D, Larsen R, Riva L and Di Fronzo G (1997) Anti-proliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr. Cancer 28: 93–99
Bruce WR (1987) Recent hypotheses for the origin of colon cancer. Cancer Res. 47: 4237–4242
Challa A, Rao DR, Chawan CB and Shackelford L (1997) Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18: 517–521
De Simone C, Vesely R, Bianchi Salvadori B and Jirillo E (1993) The role of probiotics in modulation of the immune system in man and in animals. Int. J. Immunother. 9: 23–28
Fang W-F and Strobel HW (1978) Activation of carcinogens and mutagens by rat colon mucosa. Cancer Res. 38: 2939–2944
Goldin BR and Gorbach SL (1980) Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. J. Natl. Cancer Inst. 64: 263–265
Goldin BR, Swenson L, Dwyer J, Sexton M and Gorbach SL (1980) Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J. Natl. Cancer Inst. 64: 255–261
Goldin BR and Gorbach SL (1984a) Alterations of the intestinal microflora by diet, oral antibiotics and Lactobacillus: decreased production of free amines from aromatic nitro compounds, azo dyes and glucuronides. J. Natl. Cancer Inst. 73: 689–695
Goldin BR and Gorbach SL (19846) The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. Am. J. Clin. Nutr. 39: 756–761
Kato I, Yokokura T and Mutai M (1983) Macrophage activation by Lactobacillus casei in mice. Microbiol. Immunol. 27: 611–618
Kato I, Endo K and Yokokura T (1994) Effects of oral adminstration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Int. J. Immunopharmacol. 16: 29–36
Kulkami N and Reddy BS (1994) Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial ß-glucuronidase. Proc. Soc. Exp. Biol. Med. 207: 278–283
Lidbeck A, Geltner-Allinger U, Orrhage KM, Ottava L, Brismar B, Gustafsson J-A, Rafter JJ and Nord CE (1991) Impact of Lactobacillus acidophilus supplements on the faecal microflora and soluble faecal bile acids in colon cancer patients. Microbial Ecol. Health Dis. 4: 81–88
Ling WH, Korpela R, Mykkanen H, Salminen S and Hanninen O (1994) Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J. Nutr. 124: 18–23
Matsuzaki T (1998) Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int. J. Food Microbiol. 41: 133–140
Modler GW, McKellar RC and Yaguchi M (1990) Bifidobacteria and bifidogenic factors. Can. Inst. Food Sci. Technol. J. 23: 29–41
Morotomi M and Mutai M (1986), In vitro binding of potent muta-genic pyrolysates to intestinal bacteria. J. Natl. Cancer Inst. 77: 195–201
Pool-Zobel BL, Neudecker C, Domizlaff I, Ji S, Schillinger U, Rumney C, Moretti M, Vilarini 1, Scassellati-Sforzolini R and Rowland IR (1996) Lactobacillus-and Bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr. Cancer 26: 365–380
Reddy BS (1998) Prevention of colon cancer by pre-and probiotics: evidence from laboratory studies. Br. J. Nutr. 80: S219–223
Rowland IR and Grasso P (1975) Degradation of N-nitrosamines by intestinal bacteria. Appl. Microbiol. 29: 7–12
Rowland IR, Rumney CJ, Coutts JT and Lievense LC (1998) Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19: 281–285
Schiffrin, EJ, Rochat F, Link-Amster H, Aeschlimann JM and Donnet-Hughes A (1995) Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J. Dairy Sci. 78: 491–496
Sekine K, Toida T, Saito M, Kuboyama M, Kawashima T and Hashimoto Y (1985) A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice. Cancer Res. 45: 1300–1307
Sekine K, Kawashima T and Hashimoto Y (1994) Comparison of the TNF-a levels induced by human-derived Bifidobacterium longum and rat-derived Bifidobacterium animalis in mouse peritoneal cells. Bifidobacteria Microflora 13: 79–89
Shahani KM and Ayebo AD (1980) Role of dietary lactobacilli in gastrointestinal microecology. Am. J. Clin. Nutr. 33: 2448–2457
Spanhaak S, Havenaar R and Schaafsma G (1998) The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parmeters in humans. Eur. J. Clin. Nutr. 52: 899–907
Venitt S (1988) Mutagens in human faeces and cancer of the large bowel. In: Rowland IR (Ed.), Role of the gut flora in toxicity and cancer (pp. 399–460 ). Academic Press, London
Weisburger JH and Wynder EL (1987) Etiology of colorectal cancer with emphasis on mechanism of action and prevention. In: De Vita VT, Hellman S and Rosenberg SA (Eds.), Important advances in oncology (pp. 197–220). JB Lippincott, Philadelphia
Zhang XB and Ohta Y (1993) Microorganisms in the gastrointestinal tract of the rat prevent absorption of the mutagen-carcinogen 3amino-1,4-dimethyl-5H-pyrido[4,3-b]indole. Can. J. Microbiol. 39: 841–845
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Hirayama, K., Rafter, J. (1999). The role of lactic acid bacteria in colon cancer prevention: mechanistic considerations. In: Konings, W.N., Kuipers, O.P., In ’t Veld, J.H.J.H. (eds) Lactic Acid Bacteria: Genetics, Metabolism and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-2027-4_25
Download citation
DOI: https://doi.org/10.1007/978-94-017-2027-4_25
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5312-1
Online ISBN: 978-94-017-2027-4
eBook Packages: Springer Book Archive